Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Sevabind 800mg Tablet

Prescription Icon
Prescription Required

Marketer

Qren Lifesciences Pvt Ltd

Salt Composition

Sevelamer (800mg)

Overview Sevabind 800mg Tablet

Phosphate-binding medication, Sevabind 800mg tablets, effectively manages elevated blood phosphate in dialysis patients with advanced kidney disease. By reducing intestinal phosphate absorption, it lowers serum phosphate concentrations. Administer this medication with food, following the prescribed dosage and schedule for optimal results. Consistent, daily intake at the same time is crucial. Potential side effects include gastrointestinal upset (nausea, vomiting, abdominal pain, constipation, or diarrhea), and deficiencies in calcium and certain vitamins (A, D, E, K, and folic acid) may occur. Supplementation, as directed by your physician, is recommended to address these potential deficiencies.

Uses of Sevabind 800mg Tablet

Elevated serum phosphate concentration

Major Benefits of Sevabind 800mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the 800mg Sevabind tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with a meal.

Common Side effects of Sevabind 800mg Tablet:

  • Abdominal pain
  • Diarrhea
  • Flatulence
  • Vomiting
  • Constipation
  • Nausea

How to use Sevabind 800mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the 800mg Sevabind tablet whole; avoid chewing, crushing, or fracturing it. It should be administered with food.

How Sevabind 800mg Tablet works:

Sevabind 800mg tablets reduce blood phosphate by hindering intestinal phosphate absorption.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Sevabind 800mg Tablet may pose unknown risks. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sevabind 800mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Lactation and the use of 800mg Sevabind tablets appear compatible. Available human data indicates minimal infant risk associated with this medication.

DrivingDrivingCONSULT YOUR DOCTOR

Driving ability while taking Sevabind 800mg Tablet is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.

KidneyKidneySAFE IF PRESCRIBED

Patients with kidney disease can safely take Sevabind 800mg tablets without requiring a dosage change. Nevertheless, routine monitoring of their calcium levels is recommended.

LiverLiverSAFE IF PRESCRIBED

Employing Sevabind 800mg tablets in individuals with hepatic impairment appears to pose minimal risk. Current evidence indicates that dose modification for Sevabind 800mg tablets may be unnecessary in such cases. However, physician consultation is recommended.

What if you forget to take Sevabind 800mg Tablet :

Omit any missed Sevabind 800mg Tablet dose and resume your regular dosing regimen. Avoid taking a double dose.

Facts to Know About Sevabind 800mg Tablet

LabelValue
Chemical Type Oxirane
Developing Habits No.
Treatment Category KINSHIP

FAQs on Sevabind 800mg Tablet

Yes, take Sevabind 800mg tablets with food. The recommended dosage is one to two tablets, three times daily, depending on your individual needs. This is important because the medication binds to phosphate in food. Always follow your doctor's instructions precisely.
Do not crush, chew, or break Sevabind 800mg tablets. Swallow the tablet whole with water.
Dialysis patients often struggle to regulate blood phosphate levels, particularly post-meal. Elevated phosphate can lead to various complications including itchy skin, red eyes, hypertension, bone pain, and increased fracture risk. Sevabind 800mg Tablet helps manage this by binding phosphate in the digestive tract, thereby lowering serum phosphate levels.
Sevabind 800mg Tablets may cause constipation, although this isn't experienced by all users. Other common gastrointestinal side effects include diarrhea, indigestion, gas, and abdominal pain. Seek immediate medical attention if these effects become severe or bothersome.
Sevabind 800mg Tablets should be avoided by patients with a Sevabind allergy, low blood phosphate levels, or intestinal obstruction.
Taking ciprofloxacin and Sevabind 800mg Tablet concurrently is not recommended due to potential interactions. If both are necessary, allow at least a 2-hour interval before or a 6-hour interval after taking Sevabind 800mg Tablet.
Follow your doctor's instructions for taking Sevabind 800mg Tablets. While these tablets reduce dietary phosphate, they don't cure the underlying condition, so continued use may be necessary to maintain healthy phosphate levels. Stopping treatment could lead to increased phosphate levels.
Regular monitoring of serum phosphate levels is necessary during treatment with Sevabind 800mg Tablet. Sevabind 800mg Tablet may also lower vitamin D, A, E, K, and folic acid levels, requiring monitoring of these nutrients as well.
Sevabind 800mg Tablet
337
MRP 390
13% off